Short Communication Open Access
Volume 3 | Issue 2 | DOI: https://doi.org/10.46439/neurobiology.3.017
The role of fathers on HPA-axis development and activity across the lifespan: A brief review
Erin E. Wood1, Michael M. Criss2, Jennifer Byrd-Craven1,*
- 1Department of Psychology, Oklahoma State University, Stillwater, OK, United States
- 2Department of Human Development & Family Science, Oklahoma State University, Stillwater, OK, United States
Corresponding Author
Jennifer Byrd-Craven, jennifer.byrd.craven@okstate.edu
Received Date: May 29, 2021
Accepted Date: July 12, 2021
Wood EE, Criss MM, Byrd-Craven J. The role of fathers on HPA-axis development and activity across the lifespan: A brief review. J Neurobiol Physiol 2021; 3(2):32-35.
Copyright: © 2021 Wood EE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Evaluation of the pathophysiological mechanisms of salt sensitivity
Globally, hypertension is estimated to affect 40% of adults and cause 7.5 million deaths, approximately 12.8% of all deaths. And the rate of hypertension control is still exceptionally low. There is strong evidence to suggest a causal relationship between salt intake and high blood pressure. Salt sensitivity is an independent risk factor for cardiovascular disease (CVD) and mortality, which is present in half of the hypertensive population and one quarter of the normotensive subjects. Additionally, despite the unquestionable influence of environmental factors in the determination of salt sensitivity in humans, estimates of its heritability have been as high as 74% in blacks and 50% in Chinese subjects, both higher than those for hypertension.
Potential biomarkers for MCL1 inhibitor sensitivity
Myeloid cell leukemia-1 (MCL1) is an anti-apoptotic member of the B-cell lymphoma 2 (BCL- 2) family and plays a key role in cancer cell survival and resistance to therapy [1,2]. MCL1 is often
overexpressed in cancers such as leukemia, lymphoma, and solid tumors, allowing cancer cells to evade apoptosis and resist conventional treatments.